Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Male Sexual Response: Erection & Ejaculation01:17

Male Sexual Response: Erection & Ejaculation

Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment Strategies for Psychological Disorders01:24

Treatment Strategies for Psychological Disorders

Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sexual dysfunctions in male patients with infertility: recommendations from the Fifth International Consultation for Sexual Medicine (ICSM 2024).

Sexual medicine reviews·2026
Same author

History of Peyronie's disease: from early descriptions to modern treatments.

Sexual medicine reviews·2025
Same author

Scoping review to assess the role of the immune system in the pathophysiology of vulvodynia and post-orgasmic illness syndrome.

Sexual medicine reviews·2025
Same author

Addressing unmet needs for patients with erectile dysfunction: a narrative review of topical therapies.

Sexual medicine·2025
Same author

Advances in penile prosthetics: current trends and future directions in erectile dysfunction treatment.

International journal of impotence research·2024
Same author

Oxidative Stress-Associated Male Infertility: Current Diagnostic and Therapeutic Approaches.

Medicina (Kaunas, Lithuania)·2024

Related Experiment Video

Updated: Jul 9, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

Premature ejaculation: current and future treatments.

Levent Gurkan1, Matthew Oommen, Wayne J G Hellstrom

  • 1Department of Urology, Tulane University Health Sciences Center, New Orleans, LA 70112, USA.

Asian Journal of Andrology
|December 19, 2007
PubMed
Summary

Premature ejaculation (PE) is a common male sexual disorder lacking a universal definition and FDA-approved drugs. This review explores current and emerging treatments for PE, discussing their pros and cons.

More Related Videos

Treatment of Ejaculatory Duct Obstruction by Seminal Vesiculoscopy Assisted Flow Modification
03:51

Treatment of Ejaculatory Duct Obstruction by Seminal Vesiculoscopy Assisted Flow Modification

Published on: December 8, 2023

Related Experiment Videos

Last Updated: Jul 9, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

Treatment of Ejaculatory Duct Obstruction by Seminal Vesiculoscopy Assisted Flow Modification
03:51

Treatment of Ejaculatory Duct Obstruction by Seminal Vesiculoscopy Assisted Flow Modification

Published on: December 8, 2023

Area of Science:

  • Urology
  • Andrology
  • Sexual Medicine

Background:

  • Premature ejaculation (PE) is the most prevalent male sexual dysfunction.
  • Diagnosis and treatment of PE are challenging due to the absence of a universal definition and FDA-approved medications.
  • Physicians currently manage PE using established guidelines, employing behavioral therapies or off-label drug use.

Purpose of the Study:

  • To review current and emerging treatment options for premature ejaculation (PE).
  • To discuss the advantages and limitations of various PE treatment modalities.
  • To provide an evidence-based overview for clinicians managing PE.

Main Methods:

  • Literature review of peer-reviewed publications on premature ejaculation treatments.
  • Analysis of current therapeutic strategies, including behavioral and pharmacological approaches.
  • Evaluation of the efficacy and safety profiles of existing and novel medications for PE.

Main Results:

  • Several treatment options exist for PE, including on-demand and daily medications, as well as psychosexual and device-based therapies.
  • Off-label use of certain antidepressants and topical anesthetics are common pharmacological approaches.
  • Behavioral techniques and devices offer non-pharmacological alternatives, though evidence varies.

Conclusions:

  • Effective management of PE requires a tailored approach considering individual patient factors and treatment goals.
  • Ongoing research is crucial for developing standardized definitions and FDA-approved therapies for PE.
  • A comprehensive understanding of current treatment options and their limitations is essential for optimizing patient outcomes in PE management.